Implementation of pertussis immunization in health-care personnel

Vaccine

Volumn 33, Issue 17, 2015, Pages 2009-2014

  Walther, Kathi ^a   Burckhardt, Marie Anne ^a   Erb, Thomas ^a,b   Heininger, Ulrich ^a,b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Health care personnel; Immunization; Pertussis; Tdap

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADULT; ARTICLE; COUNSELING; DRUG FEVER; HEALTH CARE PERSONNEL; HUMAN; INJECTION SITE PAIN; INJECTION SITE SWELLING; MEDICAL STUDENT; NURSE; OCCUPATIONAL HEALTH SERVICE; PERTUSSIS; PHYSICIAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; VACCINATION; ADVERSE EFFECTS; DIPHTHERIA; EDUCATION; FEMALE; IMMUNIZATION; INFANT; MALE; PREVENTIVE HEALTH SERVICE; STATISTICS AND NUMERICAL DATA; SWITZERLAND; TETANUS; WHOOPING COUGH;

ADULT; DIPHTHERIA; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEALTH PERSONNEL; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; MALE; SWITZERLAND; TETANUS; VACCINATION; WHOOPING COUGH;

EID: 84925938683     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.03.013     Document Type: Article

References (48)

1. Cherry J.D. Epidemiology of pertussis. Pediatr Infect Dis J 2006, 25(4):361-362.
2. Heininger U. Weibel D. Richard J.L. Prospective nationwide surveillance of hospitalizations due to pertussis in children, 2006-2010. Pediatr Infect Dis J 2014, 33(2):147-151.
3. Bisgard K.M. Pascual F.B. Ehresmann K.R. Miller C.A. Cianfrini C. Jennings C.E. et al. Infant pertussis: who was the source?. Pediatr Infect Dis J 2004, 23(11):985-989.
4. Wendelboe A.M. Njamkepo E. Bourillon A. Floret D.D. Gaudelus J. Gerber M. et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007, 26(4):293-299.
5. Kretsinger K. Broder K.R. Cortese M.M. Joyce M.P. Ortega-Sanchez I. Lee G.M. et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006, 55(RR-17):1-37.
6. Edwards K.M. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 2005, 24(6 Suppl.):S104-S108.
7. Zastrow R.L. Emerging infections: pertussis on the rise. Am J Nurs 2011, 111(6):51-56.
8. Cherry J.D. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005, 115(5):1422-1427.
9. Pertussis epidemic - Washington, 2012. Morb Mortal Wkly Rep 2012, 61(28):517-522.
10. Nennig M.E. Shinefield H.R. Edwards K.M. Black S.B. Fireman B.H. Prevalence and incidence of adult pertussis in an urban population. J Am Med Assoc 1996, 275(21):1672-1674.
11. Vaccines 2008, Saunders Elsevier, Elsevier Inc. Philadelphia, PA, USA. 5th ed. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
12. Lugauer S. Heininger U. Cherry J.D. Stehr K. Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur J Pediatr 2002, 161(3):142-146.
13. Witt M.A. Katz P.H. Witt D.J. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012, 54(12):1730-1735.
14. Forsyth K.D. Wirsing von Konig C.H. Tan T. Caro J. Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007, 25(14):2634-2642.
15. Bundesamt für Gesundheit Optimierung der Auffrischimpfungen gegen Diphtherie, Tetanus und Pertussis (dT/dTpa) bei Erwachsenen. BAG Bull 2011, 51:1161-1171.
16. Linnemann C.C. Ramundo N. Perlstein P.H. Minton S.D. Englender G.S. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975, 2(7934):540-543.
17. Alexander E.M. Travis S. Booms C. Kaiser A. Fry N.K. Harrison T.G. et al. Pertussis outbreak on a neonatal unit: identification of a healthcare worker as the likely source. J Hosp Infect 2008, 69(2):131-134.
18. Boulay B.R. Murray C.J. Ptak J. Kirkland K.B. Montero J. Talbot E.A. An outbreak of pertussis in a hematology-oncology care unit: implications for adult vaccination policy. Infect Control Hosp Epidemiol 2006, 27(1):92-95.
19. Bryant K.A. Humbaugh K. Brothers K. Wright J. Pascual F.B. Moran J. et al. Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker. Infect Control Hosp Epidemiol 2006, 27(6):541-545.
20. Baugh V. McCarthy N. Outbreak of Bordetella pertussis among oncology nurse specialists. Occup Med (Lond.) 2010, 60(5):401-405.
21. Maltezou H.C. Ftika L. Theodoridou M. Nosocomial pertussis in neonatal units. J Hosp Infect 2013, 85(4):243-248.
22. Ward A. Caro J. Bassinet L. Housset B. O'Brien J.A. Guiso N. Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France. Infect Control Hosp Epidemiol 2005, 26(3):288-292.
23. Calugar A. Ortega-Sanchez I.R. Tiwari T. Oakes L. Jahre J.A. Murphy T.V. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006, 42(7):981-988.
24. Bassinet L. Matrat M. Njamkepo E. Aberrane S. Housset B. Guiso N. Nosocomial pertussis outbreak among adult patients and healthcare workers. Infect Control Hosp Epidemiol 2004, 25(11):995-997.
25. Crameri S. Heininger U. Successful control of a pertussis outbreak in a university children's hospital. Int J Infect Dis 2008, 12(6):e85-e87.
26. Outbreaks of pertussis associated with hospitals - Kentucky, Pennsylvania, and Oregon, 2003. Morb Mortal Wkly Rep 2005, 54(3):67-71.
27. Wiese-Posselt M. Hellenbrand W. Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill 2010, 15(16).
28. Greer A.L. Fisman D.N. Keeping vulnerable children safe from pertussis: preventing nosocomial pertussis transmission in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2009, 30(11):1084-1089.
29. Bundesamt für Gesundheit Factsheet Diphterie, Starrkrampf, Keuchhusten 2012, Cited from: http://www.bag.admin.ch/themen/medizin/00682/00685/03212/?lang=de.
30. Michael Marcy S. Kohl K.S. Dagan R. Nalin D. Blum M. Jones M.C. et al. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004, 22(5-6):551-556.
31. Gidudu J. Kohl K.S. Halperin S. Hammer S.J. Heath P.T. Hennig R. et al. A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2008, 26(52):6800-6813.
32. Williams W.W. Lu P.J. O'Halloran A. Bridges C.B. Pilishvili T. Hales C.M. et al. Noninfluenza vaccination coverage among adults - United States, 2012. Morb Mortal Wkly Rep 2014, 63(5):95-102.
33. Pascual F.B. McCall C.L. McMurtray A. Payton T. Smith F. Bisgard K.M. Outbreak of pertussis among healthcare workers in a hospital surgical unit. Infect Control Hosp Epidemiol 2006, 27(6):546-552.
34. Baggett H.C. Duchin J.S. Shelton W. Zerr D.M. Heath J. Ortega-Sanchez I.R. et al. Two nosocomial pertussis outbreaks and their associated costs - King County, Washington, 2004. Infect Control Hosp Epidemiol 2007, 28(5):537-543.
35. Loulergue P. Fonteneau L. Armengaud J.B. Momcilovic S. Levy-Bruhl D. Launay O. et al. Vaccine coverage of healthcare students in hospitals of the Paris region in 2009: the Studyvax survey. Vaccine 2013, 31(26):2835-2838.
36. Urwyler P. Dierig A. Walther K. Heininger U. Protection against vaccine-preventable diseases in medical students: a follow up. Pediatr Infect Dis J 2014, 33(10):1057-1059.
37. Seale H. Leask J. Macintyre C.R. Do they accept compulsory vaccination? Awareness, attitudes and behaviour of hospital health care workers following a new vaccination directive. Vaccine 2009, 27(23):3022-3025.
38. Loulergue P. Moulin F. Vidal-Trecan G. Absi Z. Demontpion C. Menager C. et al. Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations. Vaccine 2009, 27(31):4240-4243.
39. Miller B.L. Ahmed F. Lindley M.C. Wortley P.M. US hospital requirements for pertussis vaccination of healthcare personnel, 2011. Infect Control Hosp Epidemiol 2011, 32(12):1209-1212.
40. Weber D.J. Consoli S.A. Sickbert-Bennett E. Rutala W.A. Assessment of a mandatory tetanus, diphtheria, and pertussis vaccination requirement on vaccine uptake over time. Infect Control Hosp Epidemiol 2012, 33(1):81-83.
41. Helms C. Leask J. Robbins S.C. Chow M.Y. McIntyre P. Implementation of mandatory immunisation of healthcare workers: observations from New South Wales, Australia. Vaccine 2011, 29(16):2895-2901.
42. Esolen L.M. Kilheeney K.L. A mandatory campaign to vaccinate health care workers against pertussis. Am J Infect Control 2013, 41(8):740-742.
43. Talbot E.A. Brown K.H. Kirkland K.B. Baughman A.L. Halperin S.A. Broder K.R. The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak. Vaccine 2010, 28(50):8001-8007.
44. Beytout J. Launay O. Guiso N. Fiquet A. Baudin M. Richard P. et al. Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial. Hum Vaccin 2009, 5(5):315-321.
45. Van Damme P. McIntyre P. Grimprel E. Kuriyakose S. Jacquet J.M. Hardt K. et al. Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix((R))) in adults 55 years of age and over: a sub-analysis of four trials. Vaccine 2011, 29(35):5932-5939.
46. Halperin S.A. McNeil S. Langley J. Blatter M. Dionne M. Embree J. et al. Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose. Vaccine 2011, 29(46):8459-8465.
47. Tomovici A. Barreto L. Zickler P. Meekison W. Noya F. Voloshen T. et al. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine 2012, 30(16):2647-2653.
48. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60(RR-7):1-45.